Cytopathology Manager of Operations Indiana University Health
BIOGRAPHY
SEP 17, 2024 9:00 AM PDT
A Paradigm Shift to Extended HPV Genotyping - Getting to the COR of the matter
Speaker
Date & Time
Date: September 17, 2024
Time: 9:00 AM (PST), 12:00 PM (EST), 6:00 PM (CET)
Abstract
Discover the latest innovations in cervical cancer prevention and molecular diagnostics. This event will showcase cutting-edge advancements in integrated molecular automation and innovative assay design, with a specific focus on transforming screening practices through HPV self-collection in healthcare settings and extended genotyping designed to enhance risk assessment.
Learning Objectives:
- Insightful Presentations: Learn from an industry leader about the impact of integrated molecular automation on laboratory efficiency and throughput.
- Innovative Assay Design: Explore the capabilities of the BD Onclarity™ HPV Assay, the first FDA-approved test for extended genotyping, designed to provide comprehensive risk assessment.
- Addressing Barriers: Understand how expanded HPV self-collection is improving screening access and patient engagement, reshaping cervical cancer screening paradigms.
Secure Your Spot:
Don't miss this opportunity to be at the forefront of transformative technologies driving the future of cervical cancer screening. Register now to join us as we shape the next era of healthcare together!
Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
JAN 14, 2026 | 10:00 AM
Join us for an insightful webinar to discuss a holistic approach to testing for TB in a clinical setting. Tuberculosis remains a global health challenge and accurate, timely diagnosis is cri...
JAN 15, 2026 | 8:00 AM
Personalized medicine promises to significantly improve patient outcomes, but achieving this requires a deep understanding of human health and disease mechanisms at the molecular level. The...
JAN 20, 2026 | 11:00 AM
CAR-T translational research demands precise, reproducible, and scalable flow cytometry workflows. Manual centrifugation and antibody preparation steps remain major sources of variability an...
JAN 20, 2026 | 9:15 AM
Bloodstream infections (BSIs) remain a critical challenge in clinical care, where every hour of delay in diagnosis can significantly impact patient outcomes. This webinar explores findings f...
JAN 21, 2026 | 8:45 AM
C.E. CREDITS
Lipid nanoparticles (LNPs) have become the gold standard in non-viral gene delivery technologies, exemplified by the approval of the LNP messenger RNA (mRNA) vaccines against SARS-CoV-2. Sin...
JAN 22, 2026 | 8:00 AM
Cell line development (CLD) is often a critical bottleneck in biopharmaceutical production, often requiring labor-intensive workflows and multiple sequential screening steps that extend time...
Loading Comments...